“We have 29 hospitals, 16 clinics and over 60 diagnostic centres in Kenya, Nigeria, India, Pakistan, and Bangladesh, and we believe in making the best use of technological developments to provide accessible, affordable, and effective services that enhance life expectancy, quality of life, diagnostic and treatment options,” said Massimiliano Colella, CEO of the Evercare Group. “We chose UpToDate Advanced to support us in this endeavor and to help our clinicians make the most appropriate care decisions for every patient, every time.”
UpToDate Advanced is a new generation of clinical decision support that leverages evidence-based content in UpToDate to address knowledge gaps affecting care quality today. Evercare Group selected UpToDate Advanced for its Pathways which provide interactive guidance along critical decision points, personalized for each patient. UpToDate Pathways will also be used in the development of local clinical pathways that are specific to the hospital and designed to improve quality performance metrics through the adoption of evidence-based medicine.
“We are honored to support the Evercare Group in their efforts to provide the best clinical outcomes for every patient,” commented Denise Basow, MD, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health. “Their far-reaching commitment to reducing variations in care with UpToDate Advanced truly embodies our mission to deliver deep impact when and where it matters most.”
